Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002117.SZ Stock Summary
Top 10 Correlated ETFs
002117.SZ
In the News
002117.SZ Financial details
Company Rating
Buy
Market Cap
4.43B
Income
163.31M
Revenue
1.2B
Book val./share
2.87
Cash/share
1.56
Dividend
0.22
Dividend %
2.72%
Employees
1.35K
Optionable
No
Shortable
Yes
Earnings
23 Apr 2024
P/E
29.36
Forward P/E
-
PEG
14.92
P/S
3.66
P/B
2.87
P/C
5.11
P/FCF
101.36
Quick Ratio
2.24
Current Ratio
2.56
Debt / Equity
0.08
LT Debt / Equity
0.02
-
-
EPS (TTM)
0.3
EPS next Y
-
EPS next Q
-
EPS this Y
20%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-9.35%
Revenue last 5Y
-4.58%
Revenue Q/Q
-3.21%
EPS Q/Q
-39.88%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-11.11%
Inst Own
-
Inst Trans
-
ROA
8%
ROE
10%
ROC
0.11%
Gross Margin
34%
Oper. Margin
14%
Profit Margin
12%
Payout
1%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.41-12.1
52W High
-33.58%
52W Low
+59.4%
RSI
47
Rel Volume
0.79
Avg Volume
8.74M
Volume
6.91M
Perf Week
-4.44%
Perf Month
4.87%
Perf Quarter
-3.86%
Perf Half Y
-8.91%
-
-
-
-
Beta
0.576
-
-
Volatility
0.33%, 0.31%
Prev Close
1.53%
Price
7.97
Change
6.41%
002117.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.74 | 2.16 | 2.2 | 1.95 | 2.17 | |
Net income per share | 0.49 | 0.3 | 0.34 | 0.25 | 0.3 | |
Operating cash flow per share | 0.78 | 0.48 | 0.35 | 0.29 | 0.4 | |
Free cash flow per share | 0.61 | 0.42 | 0.27 | 0.21 | 0.35 | |
Cash per share | 1.65 | 1.67 | 1.6 | 1.52 | 1.56 | |
Book value per share | 3 | 2.9 | 2.87 | 2.82 | 2.87 | |
Tangible book value per share | 2.79 | 2.72 | 2.73 | 2.69 | 2.72 | |
Share holders equity per share | 3 | 2.9 | 2.87 | 2.82 | 2.87 | |
Interest debt per share | 0.02 | 0.24 | 0.06 | 0.08 | 0.23 | |
Market cap | 6.79B | 4.75B | 4.55B | 4.15B | 4.63B | |
Enterprise value | 6.45B | 4.16B | 3.82B | 3.35B | 3.94B | |
P/E ratio | 25.47 | 29.07 | 24.37 | 30.81 | 28.33 | |
Price to sales ratio | 4.54 | 4.02 | 3.78 | 3.89 | 3.91 | |
POCF ratio | 16.05 | 18.17 | 23.7 | 25.85 | 21.02 | |
PFCF ratio | 20.37 | 20.8 | 31.16 | 35.61 | 24.14 | |
P/B Ratio | 4.15 | 3 | 2.9 | 2.7 | 2.95 | |
PTB ratio | 4.15 | 3 | 2.9 | 2.7 | 2.95 | |
EV to sales | 4.31 | 3.53 | 3.18 | 3.15 | 3.33 | |
Enterprise value over EBITDA | 16.6 | 16.45 | 12.88 | 14.52 | 15.6 | |
EV to operating cash flow | 15.24 | 15.94 | 19.92 | 20.92 | 17.9 | |
EV to free cash flow | 19.33 | 18.24 | 26.19 | 28.81 | 20.57 | |
Earnings yield | 0.04 | 0.03 | 0.04 | 0.03 | 0.04 | |
Free cash flow yield | 0.05 | 0.05 | 0.03 | 0.03 | 0.04 | |
Debt to equity | 0.01 | 0.08 | 0.02 | 0.03 | 0.08 | |
Debt to assets | 0.01 | 0.06 | 0.01 | 0.02 | 0.06 | |
Net debt to EBITDA | -0.89 | -2.31 | -2.44 | -3.43 | -2.71 | |
Current ratio | 2.05 | 1.96 | 2.15 | 2.02 | 2.19 | |
Interest coverage | 48.72K | 649.39 | 195.33 | 86.6 | 82.23 | |
Income quality | 1.58 | 1.59 | 1.02 | 1.18 | 1.35 | |
Dividend Yield | 0.04 | 0.05 | 0.05 | 0.04 | 0.03 | |
Payout ratio | 0.95 | 1.34 | 1.17 | 1.23 | 0.73 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0.06 | 0.08 | 0.06 | 0.07 | 0.05 | |
Intangibles to total assets | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -0.21 | -0.13 | -0.24 | -0.27 | -0.13 | |
Capex to revenue | -0.06 | -0.03 | -0.04 | -0.04 | -0.02 | |
Capex to depreciation | -1.2 | -0.45 | -0.63 | -0.59 | -0.35 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | -0.17 | |
Graham number | 5.75 | 4.42 | 4.7 | 3.96 | 4.4 | |
ROIC | 0.16 | 0.1 | 0.12 | 0.09 | 0.09 | |
Return on tangible assets | 0.12 | 0.07 | 0.09 | 0.06 | 0.08 | |
Graham Net | 0.92 | 0.87 | 0.92 | 0.83 | 0.9 | |
Working capital | 689.29M | 648.77M | 681.6M | 664.84M | 714.73M | |
Tangible asset value | 1.52B | 1.49B | 1.49B | 1.47B | 1.49B | |
Net current asset value | 652.01M | 621.22M | 644.54M | 626.31M | 672.8M | |
Invested capital | 0.01 | 0.08 | 0.02 | 0.03 | 0.08 | |
Average receivables | 363.75M | 296.53M | 256.45M | 270.71M | 278.78M | |
Average payables | 352.32M | 310.45M | 231.07M | 219.69M | 199.98M | |
Average inventory | 109.54M | 113.88M | 134.78M | 163.59M | 179.58M | |
Days sales outstanding | 78.76 | 83.56 | 73.72 | 102.43 | 79.8 | |
Days payables outstanding | 145.93 | 133.3 | 94.95 | 131.59 | 70.16 | |
Days of inventory on hand | 46.56 | 57.2 | 75.85 | 92.42 | 85.11 | |
Receivables turnover | 4.63 | 4.37 | 4.95 | 3.56 | 4.57 | |
Payables turnover | 2.5 | 2.74 | 3.84 | 2.77 | 5.2 | |
Inventory turnover | 7.84 | 6.38 | 4.81 | 3.95 | 4.29 | |
ROE | 0.16 | 0.1 | 0.12 | 0.09 | 0.1 | |
Capex per share | -0.16 | -0.06 | -0.08 | -0.08 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.59 | 0.56 | 0.47 | 0.59 | 0.57 | |
Net income per share | 0.03 | 0.09 | 0.08 | 0.09 | 0.05 | |
Operating cash flow per share | 0.03 | 0.09 | 0.04 | 0.06 | 0.52 | |
Free cash flow per share | -0.02 | 0.07 | 0.04 | 0.05 | 0.49 | |
Cash per share | 1.52 | 1.24 | 1.06 | 1.1 | 1.56 | |
Book value per share | 2.82 | 2.88 | 2.73 | 2.82 | 2.87 | |
Tangible book value per share | 2.69 | 2.74 | 2.59 | 2.68 | 2.72 | |
Share holders equity per share | 2.82 | 2.88 | 2.73 | 2.82 | 2.87 | |
Interest debt per share | 0.07 | 0.07 | 0.07 | 0.06 | 0.23 | |
Market cap | 4.15B | 5.35B | 5.75B | 4.95B | 4.63B | |
Enterprise value | 3.35B | 5.29B | 5.63B | 4.87B | 3.94B | |
P/E ratio | 67.2 | 28.84 | 34.43 | 26.37 | 40.98 | |
Price to sales ratio | 12.86 | 17.58 | 22.66 | 15.28 | 14.76 | |
POCF ratio | 268.8 | 115.37 | 253.29 | 147.4 | 16.37 | |
PFCF ratio | -333.58 | 138.15 | 275.23 | 165.45 | 17.31 | |
P/B Ratio | 2.7 | 3.41 | 3.86 | 3.22 | 2.95 | |
PTB ratio | 2.7 | 3.41 | 3.86 | 3.22 | 2.95 | |
EV to sales | 10.4 | 17.38 | 22.18 | 15.03 | 12.57 | |
Enterprise value over EBITDA | 281.15 | 90.79 | 103.93 | 86.3 | 123.31 | |
EV to operating cash flow | 217.45 | 114.04 | 247.99 | 144.99 | 13.94 | |
EV to free cash flow | -269.85 | 136.56 | 269.47 | 162.74 | 14.75 | |
Earnings yield | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0.01 | 0 | 0.01 | 0.06 | |
Debt to equity | 0.03 | 0.03 | 0.02 | 0.02 | 0.08 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 | |
Net debt to EBITDA | -66.39 | -1.06 | -2.22 | -1.43 | -21.45 | |
Current ratio | 2.02 | 2.59 | 2.12 | 2.56 | 2.19 | |
Interest coverage | -330.86 | 126.89 | 111.56 | 143.56 | 14 | |
Income quality | 1 | 1 | 0.54 | 0.72 | 10.01 | |
Dividend Yield | 0 | 0 | 0.02 | 0 | 0 | |
Payout ratio | 0.12 | 0 | 2.87 | 0 | 0 | |
Sales general and administrative to revenue | -0.13 | 0.07 | -0.05 | 0.16 | -0.13 | |
Research and developement to revenue | 0.06 | 0.05 | 0.07 | 0.05 | 0.05 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex to operating cash flow | -1.81 | -0.16 | -0.08 | -0.11 | -0.05 | |
Capex to revenue | -0.09 | -0.03 | -0.01 | -0.01 | -0.05 | |
Capex to depreciation | -1.34 | -0.38 | -0.09 | 0.1 | -0.75 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.34 | 2.35 | 2.17 | 2.34 | 1.83 | |
ROIC | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 | |
Return on tangible assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
Graham Net | 0.83 | 0.93 | 0.7 | 0.88 | 0.9 | |
Working capital | 664.84M | 702.76M | 619.5M | 675.77M | 714.73M | |
Tangible asset value | 1.47B | 1.49B | 1.41B | 1.46B | 1.49B | |
Net current asset value | 626.31M | 661.93M | 583.95M | 647.13M | 672.8M | |
Invested capital | 0.03 | 0.03 | 0.02 | 0.02 | 0.08 | |
Average receivables | 300.97M | 313.05M | 359.72M | 380.83M | 314.08M | |
Average payables | 215.2M | 216.23M | 209.13M | 211.13M | 171.48M | |
Average inventory | 162.96M | 154.97M | 165.96M | 164.32M | 159.62M | |
Days sales outstanding | 83.38 | 96.72 | 139.05 | 102.67 | 74.27 | |
Days payables outstanding | 90.86 | 87.3 | 138.21 | 80.46 | 62.47 | |
Days of inventory on hand | 63.81 | 64.23 | 116.08 | 56.56 | 75.78 | |
Receivables turnover | 1.08 | 0.93 | 0.65 | 0.88 | 1.21 | |
Payables turnover | 0.99 | 1.03 | 0.65 | 1.12 | 1.44 | |
Inventory turnover | 1.41 | 1.4 | 0.78 | 1.59 | 1.19 | |
ROE | 0.01 | 0.03 | 0.03 | 0.03 | 0.02 | |
Capex per share | -0.05 | -0.01 | 0 | -0.01 | -0.03 |
002117.SZ Frequently Asked Questions
What is Tungkong Inc. stock symbol ?
Tungkong Inc. is a CN stock and trading under the symbol 002117.SZ
What is Tungkong Inc. stock quote today ?
Tungkong Inc. stock price is $7.97 today.
Is Tungkong Inc. stock public?
Yes, Tungkong Inc. is a publicly traded company.